Table 1. Open in new tab Ebola Viral RNA...

ETU, EbolaTreatment Unit

In-House NP qRT-PCR

RealStar Filovirus

Ebola Xpert

All Tests Combined

Months

Samples

Patients

Samples

Patients

Samples

Patients

Samples

Patients

N+/Ntested (%)

0–3

7/24 (29.2)

6/19 (31.2)

2/3 (66.7)

1/2 (50.0)

8/8 (100.0)

7/7 (100.0)

12/24 (50.0)

10/19 (52.6)

>3–6

4/28 (14.3)

4/26 (15.4)

2/14 (14.3)

2/13 (15.4)

10/14 (71.4)

9/13 (69.2)

13/34 (38.2)

12/29 (41.4)

>6–9

5/52 (9.6)

5/47 (10.6)

0/25 (0.0)

0/20 (0.0)

6/21 (28.6)

5/18 (27.8)

10/62 (16.1)

9/54 (16.7)

>9–12

1/76 (1.3)

1/62 (1.6)

0/51 (0.0)

0/41 (0.0)

6/37 (15.2)

6/36 (16.7)

7/107 (6.6)

7/81 (8.7)

>12–15

0/69 (0.0)

0/61 (0.0)

0/78 (0.0)

0/69 (0.0)

5/45 (11.1)

5/108 (4.6)

5/93 (5.4)

>15–18

1/51 (1.9)

1/49 (2.1)

1/86 (1.2)

1/78 (1.3)

1/45 (2.2)

1/44 (2.3)

1/111 (0.9)

1/95 (1.1)

>18–21

0/77 (0.0)

0/76 (0.0)

0/131 (0.0)

0/110 (0.0)

0/41 (0.0)

0/39 (0.0)

0/169 (0.0)

0/137 (0.0)

>21–24

0/80 (0.0)

0/74 (0.0)

0/93 (0.0)

0/81 (0.0)

0/9 (0.0)

0/143 (0.0)

0/122 (0.0)

>24–27

0/50 (0.0)

0/49 (0.0)

0/10 (0.0)

0/104 (0.0)

0/101 (0.0)

>27–30

0/20 (0.0)

0/19 (0.0)

0/40 (0.0)

0/18 (0.0)

0/76 (0.0)

0/75 (0.0)

>30–33

0/4 (0.0)

0/35 (0.0)

0/34 (0.0)

0/25 (0.0)

0/63 (0.0)

>33–36

0/15 (0.0)

0/54 (0.0)

0/53 (0.0)

0/69 (0.0)

0/68 (0.0)

>36–39

0/54 (0.0)

>39–42

0/59 (0.0)

>42–45

0/46 (0.0)

>45–48

0/65 (0.0)

>48–51

0/52 (0.0)

>51–54

0/15 (0.0)

>54–57

0/7 (0.0)

Total

18/531 (3.4)

14/225 (6.2)

5/620 (0.8)

3/243 (1.2)

36/626 (5.8)

23/238 (9.7)

47/1368 (3.4)

27/277 (9.8)

Table 1.

Open in new tab

Ebola Viral RNA Detection in Semen Samples for Different Periods After Discharge From Ebola Treatment Center Using Different RNA Detection Assays

ETU, EbolaTreatment Unit	In-House NP qRT-PCR		RealStar Filovirus		Ebola Xpert		All Tests Combined
Months	Samples	Patients	Samples	Patients	Samples	Patients	Samples	Patients
	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)
0–3	7/24 (29.2)	6/19 (31.2)	2/3 (66.7)	1/2 (50.0)	8/8 (100.0)	7/7 (100.0)	12/24 (50.0)	10/19 (52.6)
>3–6	4/28 (14.3)	4/26 (15.4)	2/14 (14.3)	2/13 (15.4)	10/14 (71.4)	9/13 (69.2)	13/34 (38.2)	12/29 (41.4)
>6–9	5/52 (9.6)	5/47 (10.6)	0/25 (0.0)	0/20 (0.0)	6/21 (28.6)	5/18 (27.8)	10/62 (16.1)	9/54 (16.7)
>9–12	1/76 (1.3)	1/62 (1.6)	0/51 (0.0)	0/41 (0.0)	6/37 (15.2)	6/36 (16.7)	7/107 (6.6)	7/81 (8.7)
>12–15	0/69 (0.0)	0/61 (0.0)	0/78 (0.0)	0/69 (0.0)	5/45 (11.1)	5/45 (11.1)	5/108 (4.6)	5/93 (5.4)
>15–18	1/51 (1.9)	1/49 (2.1)	1/86 (1.2)	1/78 (1.3)	1/45 (2.2)	1/44 (2.3)	1/111 (0.9)	1/95 (1.1)
>18–21	0/77 (0.0)	0/76 (0.0)	0/131 (0.0)	0/110 (0.0)	0/41 (0.0)	0/39 (0.0)	0/169 (0.0)	0/137 (0.0)
>21–24	0/80 (0.0)	0/74 (0.0)	0/93 (0.0)	0/81 (0.0)	0/9 (0.0)	0/9 (0.0)	0/143 (0.0)	0/122 (0.0)
>24–27	0/50 (0.0)	0/50 (0.0)	0/49 (0.0)	0/49 (0.0)	0/10 (0.0)	0/10 (0.0)	0/104 (0.0)	0/101 (0.0)
>27–30	0/20 (0.0)	0/19 (0.0)	0/40 (0.0)	0/40 (0.0)	0/18 (0.0)	0/18 (0.0)	0/76 (0.0)	0/75 (0.0)
>30–33	0/4 (0.0)	0/4 (0.0)	0/35 (0.0)	0/34 (0.0)	0/25 (0.0)	0/25 (0.0)	0/63 (0.0)	0/63 (0.0)
>33–36	nd	nd	0/15 (0.0)	0/15 (0.0)	0/54 (0.0)	0/53 (0.0)	0/69 (0.0)	0/68 (0.0)
>36–39	nd	nd	nd	nd	0/54 (0.0)	0/54 (0.0)	0/54 (0.0)	0/54 (0.0)
>39–42	nd	nd	nd	nd	0/59 (0.0)	0/59 (0.0)	0/59 (0.0)	0/59 (0.0)
>42–45	nd	nd	nd	nd	0/46 (0.0)	0/46 (0.0)	0/46 (0.0)	0/46 (0.0)
>45–48	nd	nd	nd	nd	0/65 (0.0)	0/65 (0.0)	0/65 (0.0)	0/65 (0.0)
>48–51	nd	nd	nd	nd	0/52 (0.0)	0/52 (0.0)	0/52 (0.0)	0/52 (0.0)
>51–54	nd	nd	nd	nd	0/15 (0.0)	0/15 (0.0)	0/15 (0.0)	0/15 (0.0)
>54–57	nd	nd	nd	nd	0/7 (0.0)	0/7 (0.0)	0/7 (0.0)	0/7 (0.0)
Total	18/531 (3.4)	14/225 (6.2)	5/620 (0.8)	3/243 (1.2)	36/626 (5.8)	23/238 (9.7)	47/1368 (3.4)	27/277 (9.8)

ETU, EbolaTreatment Unit	In-House NP qRT-PCR		RealStar Filovirus		Ebola Xpert		All Tests Combined
Months	Samples	Patients	Samples	Patients	Samples	Patients	Samples	Patients
	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)	N+/Ntested (%)
0–3	7/24 (29.2)	6/19 (31.2)	2/3 (66.7)	1/2 (50.0)	8/8 (100.0)	7/7 (100.0)	12/24 (50.0)	10/19 (52.6)
>3–6	4/28 (14.3)	4/26 (15.4)	2/14 (14.3)	2/13 (15.4)	10/14 (71.4)	9/13 (69.2)	13/34 (38.2)	12/29 (41.4)
>6–9	5/52 (9.6)	5/47 (10.6)	0/25 (0.0)	0/20 (0.0)	6/21 (28.6)	5/18 (27.8)	10/62 (16.1)	9/54 (16.7)
>9–12	1/76 (1.3)	1/62 (1.6)	0/51 (0.0)	0/41 (0.0)	6/37 (15.2)	6/36 (16.7)	7/107 (6.6)	7/81 (8.7)
>12–15	0/69 (0.0)	0/61 (0.0)	0/78 (0.0)	0/69 (0.0)	5/45 (11.1)	5/45 (11.1)	5/108 (4.6)	5/93 (5.4)
>15–18	1/51 (1.9)	1/49 (2.1)	1/86 (1.2)	1/78 (1.3)	1/45 (2.2)	1/44 (2.3)	1/111 (0.9)	1/95 (1.1)
>18–21	0/77 (0.0)	0/76 (0.0)	0/131 (0.0)	0/110 (0.0)	0/41 (0.0)	0/39 (0.0)	0/169 (0.0)	0/137 (0.0)
>21–24	0/80 (0.0)	0/74 (0.0)	0/93 (0.0)	0/81 (0.0)	0/9 (0.0)	0/9 (0.0)	0/143 (0.0)	0/122 (0.0)
>24–27	0/50 (0.0)	0/50 (0.0)	0/49 (0.0)	0/49 (0.0)	0/10 (0.0)	0/10 (0.0)	0/104 (0.0)	0/101 (0.0)
>27–30	0/20 (0.0)	0/19 (0.0)	0/40 (0.0)	0/40 (0.0)	0/18 (0.0)	0/18 (0.0)	0/76 (0.0)	0/75 (0.0)
>30–33	0/4 (0.0)	0/4 (0.0)	0/35 (0.0)	0/34 (0.0)	0/25 (0.0)	0/25 (0.0)	0/63 (0.0)	0/63 (0.0)
>33–36	nd	nd	0/15 (0.0)	0/15 (0.0)	0/54 (0.0)	0/53 (0.0)	0/69 (0.0)	0/68 (0.0)
>36–39	nd	nd	nd	nd	0/54 (0.0)	0/54 (0.0)	0/54 (0.0)	0/54 (0.0)
>39–42	nd	nd	nd	nd	0/59 (0.0)	0/59 (0.0)	0/59 (0.0)	0/59 (0.0)
>42–45	nd	nd	nd	nd	0/46 (0.0)	0/46 (0.0)	0/46 (0.0)	0/46 (0.0)
>45–48	nd	nd	nd	nd	0/65 (0.0)	0/65 (0.0)	0/65 (0.0)	0/65 (0.0)
>48–51	nd	nd	nd	nd	0/52 (0.0)	0/52 (0.0)	0/52 (0.0)	0/52 (0.0)
>51–54	nd	nd	nd	nd	0/15 (0.0)	0/15 (0.0)	0/15 (0.0)	0/15 (0.0)
>54–57	nd	nd	nd	nd	0/7 (0.0)	0/7 (0.0)	0/7 (0.0)	0/7 (0.0)
Total	18/531 (3.4)	14/225 (6.2)	5/620 (0.8)	3/243 (1.2)	36/626 (5.8)	23/238 (9.7)	47/1368 (3.4)	27/277 (9.8)

Abbreviations: nd, not done; NP, nucleoprotein; qRT-PCR, quantitative reverse-transcription polymerase chain reaction; RNA, ribonucleic acid.

This Feature Is Available To Subscribers Only